Luye Pharma Group (OTCMKTS:LYPHF – Get Free Report) is expected to be releasing its results before the market opens on Monday, March 30th. Analysts expect Luye Pharma Group to post earnings of $0.0114 per share and revenue of $494.0430 million for the quarter.
Luye Pharma Group Stock Performance
Shares of LYPHF stock opened at $0.38 on Monday. The firm has a 50-day moving average of $0.38 and a 200-day moving average of $0.34. Luye Pharma Group has a one year low of $0.37 and a one year high of $0.40.
Luye Pharma Group Company Profile
Luye Pharma Group Ltd. is a China-based pharmaceutical company headquartered in Yantai, Shandong Province. Established in 1994, the company specializes in the research, development, manufacturing and marketing of a broad portfolio of medicaments and health-care products. Luye Pharma structures its operations across three main segments: innovative drugs, generic drugs and over-the-counter (OTC) health and wellness products. Through in-house R&D and strategic collaborations, the company aims to address unmet medical needs in both domestic and international markets.
The company’s product offerings encompass key therapeutic areas such as oncology, cardiovascular disease, gastroenterology and respiratory illnesses.
Read More
Receive News & Ratings for Luye Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luye Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
